-
Symbol
-
ARWR on Nasdaq
-
Investment type
-
Equity / Common stock, par value $0.001 per share (the "Common Stock")
-
Latest Disclosed Shares Owned
-
19,012,855 shares
-
Security Ownership %
-
14%
Shares, Excluding Options vs Price
Value, Excluding Options
BlackRock, Inc. ownership in ARROWHEAD PHARMACEUTICALS, INC. Common stock, par value $0.001 per share (the "Common Stock") (ARWR)
23 Apr 2025 - BlackRock, Inc. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 19,012,855 shares of ARROWHEAD PHARMACEUTICALS, INC. Common stock, par value $0.001 per share (the "Common Stock") (ARWR).
This represents 14% ownership of the company.
This is the first filing by BlackRock, Inc. disclosing ownership of ARROWHEAD PHARMACEUTICALS, INC. Common stock, par value $0.001 per share (the "Common Stock") (ARWR).
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.